STOCKHOLM, Sweden--(BUSINESS WIRE)--Regulatory News: The Swedish company Q-Med AB (STO:QMED) today announced the execution of an international distribution agreement with Palomar Medical Technologies, Inc. (NASDAQ:PMTI), a leading researcher and developer of light-based systems for cosmetic treatments. Q-Med AB will eventually be responsible for the marketing, advertising, promotion, sale and distribution of Palomar’s professional products for esthetic treatments outside North America. Q-Med AB is the producer of Restylane®, one of the most popular and widely distributed dermal filler in the world, with over 9 million treatments provided so far. Q-Med sells Restylane® globally through a network of wholly owned sales companies, distributors and partners.
